Status:
COMPLETED
Randomized Trial of Iron Supplementation to Prevent Anemia in Very-low-birth-weight Infants
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Anemia
Eligibility:
All Genders
Up to 8 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to determine if iron supplementation in addition to routine iron intake decreases the risk of developing anemia in preterm infants.
Detailed Description
Objective was to determine if iron supplementation of 2 mg/kg per day, in addition to routine iron-fortified formula or mother's milk, increased the hematocrit (Hct) at 36 weeks' postmenstrual age (PM...
Eligibility Criteria
Inclusion
- birth weight: \< 1500 grams
- Tolerating iron fortified preterm formula or fortified breast milk at 120cc/kg/day by 8 weeks of age
- ≤32 weeks adjusted post-menstrual age at the time of enrollment
Exclusion
- cyanotic heart disease
- bowel resection prior to enrollment
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01224236
Start Date
July 1 2010
End Date
February 1 2012
Last Update
June 19 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Memorial Hermann Hospital
Houston, Texas, United States, 77030